DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 884 filers reported holding DANAHER CORPORATION in Q4 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $314,000 | -22.3% | 4,000 | 0.0% | 0.89% | -36.7% |
| Q2 2016 | $404,000 | +6.6% | 4,000 | 0.0% | 1.41% | +39.9% |
| Q1 2016 | $379,000 | +1.9% | 4,000 | 0.0% | 1.01% | +5.4% |
| Q4 2015 | $372,000 | +9.1% | 4,000 | 0.0% | 0.96% | +4.7% |
| Q3 2015 | $341,000 | -0.3% | 4,000 | 0.0% | 0.91% | +22.9% |
| Q2 2015 | $342,000 | +0.6% | 4,000 | 0.0% | 0.74% | +39.1% |
| Q1 2015 | $340,000 | -0.9% | 4,000 | 0.0% | 0.53% | +9.4% |
| Q4 2014 | $343,000 | +12.8% | 4,000 | 0.0% | 0.49% | +147.7% |
| Q3 2014 | $304,000 | -3.5% | 4,000 | 0.0% | 0.20% | -3.9% |
| Q2 2014 | $315,000 | +5.0% | 4,000 | 0.0% | 0.20% | -11.3% |
| Q1 2014 | $300,000 | -2.9% | 4,000 | 0.0% | 0.23% | -23.5% |
| Q4 2013 | $309,000 | – | 4,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
| Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
| Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
| CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
| MIROVA | 128,368 | $16,947,000 | 9.18% |
| Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
| Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
| Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
| Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |